These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16099335)

  • 1. Plasma prekallikrein as a risk factor for diabetic retinopathy.
    Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
    Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
    Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
    Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevated plasma prekallikrein level in patients with diabetes].
    Ciechanowicz A; Ciechanowski K; Pynka S; Majkowska L; Fuchs H; Mamos E; Ryszkiewicz D; Miks B; Kawiak J; Czekalski S
    Pol Arch Med Wewn; 1995 Aug; 94(2):105-11. PubMed ID: 8596745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of spontaneous fibrinolytic activity in diabetic retinopathy.
    Ostermann H; Tschöpe D; Greber W; Meyer-Rüsenberg HW; van de Loo J
    Thromb Haemost; 1992 Oct; 68(4):400-3. PubMed ID: 1448770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
    Caliumi C; Balducci S; Petramala L; Cotesta D; Zinnamosca L; Cianci R; Di Donato D; Vingolo EM; Fallucca F; Letizia C
    Minerva Endocrinol; 2007 Jun; 32(2):73-8. PubMed ID: 17557032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
    Seghieri G; Bartolomei G; De Giorgio LA
    Diabete Metab; 1986 Aug; 12(4):186-90. PubMed ID: 3770274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of blood protein levels between diabetic and non-diabetic patients with retinopathy.
    Gul A; Rahman MA
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):408-11. PubMed ID: 16787618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.
    Brooks AM; Hussein S; Chesterman CN; Martin JF; Alford FP; Penington DG
    Thromb Haemost; 1983 Apr; 49(2):123-7. PubMed ID: 6223403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinogen level in patients with type I diabetes with and without retinopathy].
    Sobol A
    Acta Haematol Pol; 1995; 26(1):57-62. PubMed ID: 7747564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for diabetic retinopathy in Kuwaiti type 2 diabetic patients.
    Al-Adsani AM
    Saudi Med J; 2007 Apr; 28(4):579-83. PubMed ID: 17457481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte membrane anionic content and urinary glycosaminoglycan excretion in type 1 diabetes: association with retinopathy.
    Yenice O; Kazokoğlu H; Ozcan E; Yüksel M; Adigüzel G; Haklar G; Yavuz DG
    Curr Eye Res; 2006 Nov; 31(11):975-81. PubMed ID: 17114123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
    Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL
    Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
    Pan HZ; Zhang H; Chang D; Li H; Sui H
    Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy].
    Skopiński P; Duda-Król B; Lipińska A; Sommer E; Borowska A; Filewska M; Szaflik J; Skopińska-Rózewska E; Struzik E
    Klin Oczna; 2004; 106(3 Suppl):424-6. PubMed ID: 15636223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheologic factors in hypertensive and diabetic retinopathy].
    Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B
    Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.